Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis

Neuroscience Letters

Volumn 287, Issue 3, 2000, Pages 211-214

  Poloni, Marco ^a   Facchetti, Dante ^b   Mai, Roberto ^b   Micheli, Anna ^b   Agnoletti, Laura ^b   Francolini, Gloria ^b   Mora, Gabriele ^b   Camana, Claudia ^b   Mazzini, Letizia ^b   Bachetti, Tiziana ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Cytokine; Neurodegenerative disease; Soluble tumour necrosis factor receptors; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; WEIGHT REDUCTION;

EID: 0034733968     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01177-0     Document Type: Article

References (16)

1. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 7:1996;231-240.
2. Brooks, B.R., El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial, Clinical limits of amyotrophic lateral sclerosis workshop contributors, J. Neurol. Sci., 124 (1994) S96-S107.
3. Comini L., Bachetti T., Agnoletti L., Gaia G., Curello S., Milanesi B., Volterrani M., Parrinello G., Ceconi C., Giordano A., Corti A., Ferrari R. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-α Eur. Heart J. 20:1999;1503-1513.
4. Engelhardt J.I., Appel M.D. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 47:1990;1210-1216.
5. Espevik T., Nissen-Meyer J. A highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:1986;99-105.
6. Ghezzi P., Bernardini M., Giuffrida R., Bellomo M., Manzoni C., Cornoletti D., Di Santo E., Benigni F., Mennini T. Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. Eur. Cytokine Netw. 9:1998;139-144.
7. Gurney M.E., Belton A.C., Cashman N., Antel J.P. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N. Engl. J. Med. 311:1984;933-939.
8. Medical Research Council: Aids to the Investigation of Peripheral Nerve Injuries. War Memorandum, 2nd edn. (revised), HSMO, London, 1943, pp. 11-46.
9. Mu X., He J., Anderson D.W., Trojanowski J.Q., Springer J.E. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40:1996;379-386.
10. Norris F.H. Jr, Calanchini P.R., Fallat R.J., Panachari S., Jewett B. Administration of guanidine in amyotrophic lateral sclerosis. Neurology. 24:1974;721-728.
11. Ransohoff R.M. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J. Leukocyte Biol. 62:1997;645-651.
12. Schwartz M., Solomon A., Lavie V., Ben-Bassat S., Belkin M., Cohen A. Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res. 545:1991;334-338.
13. Smith R.G., Kimura F., Harati Y., McKinley K., Stefani E., Appel S.H. Altered muscle calcium channel binding kinetics in autoimmune motorneuron disease. Muscle Nerve. 18:1995;620-627.
14. Smith R.G., Siklos L., Alexianu M.E., Engelhardt J.I., Mosier D.R., Colom L., Habib Mohamed A., Appel S.H. Autoimmunity and ALS. Neurology. 47:1996;S40-S46.
15. Tan S.V., Guiloff R.J., Henderson D.C., Gazzard B.G., Miller R. AIDS-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNF-α). J. Neurol. Sci. 138:1996;134-144.
16. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:1992;411-452.